PATIENTS CAN GAIN ACCESS TO THE

EVERSENSE® CGM SYSTEM WITH THE

PATIENT ASSISTANCE PROGRAM FROM ASCENSIA DIABETES CARE

 

 

Eversense® is the only long-term CGM system. It has an advanced sensor that sits comfortably just under the skin of the upper arm and monitors patients’ glucose levels for up to 90 days with demonstrated high accuracy.*1

 

PATIENT ASSISTANCE PROGRAM

Provides financial relief to eligible patients with a reduction of out-of-pocket costs. Eligible patients pay the first $100 of their identified out-of-pocket costs, and Ascensia may cover up to $300 of the balance of these costs. The patient is responsible for any remaining balance.†

 

ELIGIBLE PATIENTS COULD SAVE UP TO $1,200 PER YEAR ON THEIR EVERSENSE SENSOR SUPPLY.‡
CLICK HERE TO GET STARTED

 

HOW PATIENTS CAN ENROLL IN THIS PROGRAM:

  • The Patient Assistance Program will be applied to eligible patients who purchase Eversense® CGM directly through a participating Strategic Fulfillment Partner. Patients will be informed of eligibility by the Strategic Fulfillment Partner when discussing out-of-pocket costs
  • If purchasing through a Non-Participating Strategic Fulfillment Partner, the patient will need to complete and submit a form with supporting documentation. The patient will be notified by their Strategic Fulfillment Partner or Ascensia Field Support Specialists on the appropriate steps for enrollment.

 

* For an overview of Eversense CGM safety information, please visit www.eversensediabetes.com/safety-info.

Please visit www.ascensiadiabetes.com/eversense for limitations, restrictions, references and copyright information.

† If a patient does not have insurance and will be paying cash for the product, they may be eligible for the Eversense Patient Assistance Program. Limitations and Restrictions may apply.

‡ Maximum savings limit applies; and will vary depending on patient out of pocket costs. Please see Program Terms, Conditions, and Eligibility Criteria. Limitations and restrictions apply.

Eligible patients with U.S. commercial health insurance may receive up to $300 US dollars towards out-of-pocket costs per Eversense 90 day sensor procedure for up to 1 year from the

date of initial service request. Void where prohibited. Ascensia Diabetes Care reserves the right to terminate the program at any time without notice.

Reference: 1. Christiansen, M. P. et al. (2019). A prospective multicenter evaluation of the accuracy and safety of an implanted continuous glucose sensor: The precision study.

Diabetes Technology & Therapeutics, 21(5), 231-237. doi:10.1089/dia.2019.0020

Get in touch to learn more about getting started on Eversense

Please complete your contact details and an Ascensia Diabetes Care representative will follow up with you shortly.

*Field is required



Disclaimer

The Eversense® Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels in persons age 18 and older with diabetes for up to 90 days. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration twice per day, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a Health Care Provider. The Eversense CGM System is a prescription device; patients should talk to their Health Care Provider to learn more. For important safety information, see https://eversensediabetes.com/safety-info/.

Eversense, Eversense Continuous Glucose Monitoring, Eversense CGM, Eversense Sensor, Eversense Smart Transmitter, Eversense App and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, the Ascensia Diabetes Care logo and Contour are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG.
Other brands and their products are trademarks or registered trademarks of their respective holders.
Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System.
Android is a trademark of Google LLC.

© 2021 Senseonics, Incorporated. All rights reserved.
© 2021 Ascensia Diabetes Care Holdings AG. All rights reserved.